Jan De Witte - 18 Jan 2024 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
President & CEO, Director
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Issuer symbol
IART
Transactions as of
18 Jan 2024
Net transactions value
-$25,307
Form type
4
Filing time
19 Jan 2024, 16:43:25 UTC
Previous filing
20 Nov 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Options Exercise $0 +597 +3.3% $0.000000 18,947 18 Jan 2024 Direct
transaction IART Common Stock Tax liability $25,307 -597 -3.2% $42.39 18,350 18 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IART Restricted Stock Units Options Exercise $0 -597 -0.66% $0.000000 89,417 18 Jan 2024 Common Stock 597 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the second installment vested on 1/18/2024 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.